These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 5796027

  • 21. Influence of hydrocortisone on blood clotting and fibrinolysis after a standard resection of the liver in dogs.
    Hafström L, Lede R, Stehlin JS, Brown RO.
    Surg Gynecol Obstet; 1974 Dec; 139(6):860-6. PubMed ID: 4425058
    [No Abstract] [Full Text] [Related]

  • 22. COAGULATION STUDIES IN EXTRACORPOREAL CIRCULATION.
    DYBKJAER E, BERG E, KISSMEYER-NIELSEN F.
    Acta Chir Scand; 1964 Oct; 128():350-61. PubMed ID: 14211290
    [No Abstract] [Full Text] [Related]

  • 23. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME, Piatnitskaia GK, Kukaeva EA, Charnaia MA, Charnyĭ ISh.
    Anesteziol Reanimatol; 1981 Oct; (5):52-6. PubMed ID: 7325386
    [No Abstract] [Full Text] [Related]

  • 24. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.
    Basu D, Gallus A, Hirsh J, Cade J.
    N Engl J Med; 1972 Aug 17; 287(7):324-7. PubMed ID: 5041701
    [No Abstract] [Full Text] [Related]

  • 25. Improved survival rates in dogs after extracorporeal circulation by improved control of heparin levels.
    Akkerman JW, Runne WC, Sixma JJ, Zimmerman AN.
    J Thorac Cardiovasc Surg; 1974 Jul 17; 68(1):59-65. PubMed ID: 4834066
    [No Abstract] [Full Text] [Related]

  • 26. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory].
    Otteni JC, Boyer C, Girardel JM, Gauthier-Lafaye JP.
    Anesth Analg (Paris); 1969 Jul 17; 26(1):89-106. PubMed ID: 5793321
    [No Abstract] [Full Text] [Related]

  • 27. Studies on experimentally induced hypercoagulable state in rabbits.
    Izak G, Galewsky K.
    Thromb Diath Haemorrh; 1966 Jul 31; 16(1):228-42. PubMed ID: 5989043
    [No Abstract] [Full Text] [Related]

  • 28. [Heparin treatment of thromboembolic complications].
    Samama M, Kher A, Horellou MH, Conard J.
    Agressologie; 1983 Nov 31; 24(10):495-500. PubMed ID: 6367509
    [No Abstract] [Full Text] [Related]

  • 29. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
    Sessner HH, Brockhaus W, Kunzmann G, Stingl J.
    Med Welt; 1971 Jan 30; 5():187-91. PubMed ID: 5546024
    [No Abstract] [Full Text] [Related]

  • 30. [Heparin in therapeutics (author's transl)].
    Capel P.
    Rev Med Brux; 1981 Mar 30; 2(3):181-9. PubMed ID: 7015442
    [No Abstract] [Full Text] [Related]

  • 31. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC.
    Thromb Diath Haemorrh Suppl; 1973 Mar 30; 56():239-51. PubMed ID: 4617331
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH, Stier WD, Brunswig D.
    Arzneimittelforschung; 1969 Nov 30; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract] [Full Text] [Related]

  • 33. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK, Michel A.
    Can Med Assoc J; 1971 Mar 06; 104(5):385-8. PubMed ID: 5557913
    [Abstract] [Full Text] [Related]

  • 34. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K, Uriu K, Ikeda M.
    Nihon Rinsho; 2004 May 06; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract] [Full Text] [Related]

  • 35. Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs.
    Leandoer L, Bergentz SE, Nilsson IM.
    Acta Chir Scand; 1969 May 06; 135(1):1-6. PubMed ID: 5805939
    [No Abstract] [Full Text] [Related]

  • 36. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
    Roĭtman EV, Dement'eva II, Meshcheriakov AV.
    Anesteziol Reanimatol; 1997 May 06; (6):65-9. PubMed ID: 9511253
    [No Abstract] [Full Text] [Related]

  • 37. [On the mechanism of action of protamine-sulfate on some indices of blood coagulation system].
    Skipetrov VP.
    Farmakol Toksikol; 1966 May 06; 29(2):188-92. PubMed ID: 6000344
    [No Abstract] [Full Text] [Related]

  • 38. Effect of bypass surgery on coagulation-sensitive clotting factors.
    Woods JE, Kirklin JW, Owen CA, Thompson JH, Taswell HF.
    Mayo Clin Proc; 1967 Nov 06; 42(11):724-35. PubMed ID: 6053800
    [No Abstract] [Full Text] [Related]

  • 39. Recent advances in heparin structure, function and clinical usage.
    Fussi F.
    Boll Chim Farm; 1978 Oct 06; 117(10):561-74. PubMed ID: 743352
    [No Abstract] [Full Text] [Related]

  • 40. [Comparison of two schemes of administering the Russian protamine sulfate after extracorporeal circulation in cardiosurgical patients].
    Charnaia MA, Morozov IuA, Gladysheva VG, Isaeva AM.
    Anesteziol Reanimatol; 2006 Oct 06; (5):31-3. PubMed ID: 17184058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.